Fact sheet: Carnegie Medical

Fund information

Fund name
Carnegie Medical 1A EUR
Fund company manager
Carnegie Asset Management
Fund type
SIB
Fund manager(s)
Angelica Fatouros
since 01/07/2008
Mikael Svensson
since 01/11/2017
Ulf Arvidsson
since 01/11/2017
Fund objective
The investment objective of the C WorldWide Medical fund is to achieve long-term capital growth by investing globally in a limited number of companies within the healthcare sector. Most of the investments are in the major pharmaceutical companies, but also in smaller and medium-sized companies.
Benchmark
MSCI World Healthcare
Investment style
Growth
Investment method
Shares

Performance snapshot

Sector
Fund
Sector
Fund
Sector
Fund

Quick stats

1 Year return

-1.31 %

1 Year rank in sector

29/30

Sector

FO Equity - Pharma Health & Biotech

Yield
-
Fund size

£ 460.9 m

FE Risk score

160

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • North America
    76.3%
  • Continental Europe
    20.9%
  • UK
    2.8%
  • Pharmaceuticals
    43.6%
  • Biotechnology/Medical
    37.7%
  • Services
    18.7%
  • North American Equities
    76.3%
  • European Equities
    20.9%
  • UK Equities
    2.8%

Performance vs. Sector

Sector
Fund
Sector
Fund
Sector
Fund

Cumulative performance

1m6m1y3y5y
Fund-0.12 %-4.74 %-1.31 %-7.44 %71.32 %
Sector4.07 %3.17 %14.38 %11.78 %97.73 %
Rank within sector30 / 3129 / 3129 / 3026 / 2618 / 22
Quartile th4 th4 th4 th4 th4 th

Calendar performance

YTD-20182017201620152014
Fund0.76 %1.67 %-14.37 %10.68 %38.82 %
Sector3.52 %14.94 %-9.92 %7.24 %28.08 %
Rank within sector31 / 3128 / 3020 / 3010 / 264 / 23
Quartile th4 th4 th3 rd2 nd1 st

Risk statistics

Alpha-4.67
Beta1.11
Sharpe-0.01
Volatility18.24
Tracking error7.07
Information ratio-0.65
R-Squared0.86

Price movement

52 week high101.85
52 week low89.19
Current bid price0
Current offer price0
Current mid price92.6

Holdings by region

  • 76.3% North America
  • 20.9% Continental Europe
  • 2.8% UK

Holdings by sector

  • 43.6% Pharmaceuticals
  • 37.7% Biotechnology/Medical
  • 18.7% Services

Holdings by asset type

  • 76.3% North American Equities
  • 20.9% European Equities
  • 2.8% UK Equities

Individual holdings

  • 7.7% JOHNSON & JOHNSON
  • 7.4% UNITEDHEALTH GROUP INC
  • 5.2% C WORLDWIDE MEDICAL SMALL & MID CAP
  • 5.1% GILEAD SCIENCES INC
  • 4.4% ROCHE HLDG AG
  • 3.6% AMGEN INC
  • 3.4% PFIZER INC
  • 3.3% CELGENE CORP
  • 3.2% ACTAVIS INC
  • 3.2% THERMO FISHER SCIENTIFIC INC